Skip to content

Serum IgM to Enterocyte Antibody (Qualitative)

Published: August 9, 2026Updated: August 16, 2026

This test measures antibodies in your blood that may react with enterocytes, specialized cells lining the intestines. It helps identify potential autoimmune or inflammatory conditions affecting digestion.

Quick summary

["This screening may help detect hidden intestinal issues linked to immune responses."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
69032-1
Short code
Enterocyte IgM Ser Ql
Synonyms
Enterocyte IgM Ser Ql
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
82784
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms like persistent abdominal pain, unexplained diarrhea, weight loss, or a history of gastrointestinal issues. It could also be used in research or specialized diagnostic protocols for conditions like inflammatory bowel disease or unexplained chronic diarrhea.

What to Expect Before the Test

No special preparation is needed. You’ll have a simple blood draw, usually from your arm, similar to other routine blood tests. The sample will be sent to a lab for analysis.

What the Results Mean

A positive result indicates the presence of antibodies against enterocytes, which may suggest an immune-mediated process affecting your intestines. A negative result means no detectable antibodies were found in this test. Results alone don’t diagnose a specific condition; they’re often part of a broader evaluation.

Common Conditions Monitored

This test may be used in research or specialized settings to monitor conditions like autoimmune enteropathy, chronic inflammatory bowel disease, or other gastrointestinal disorders where intestinal cell antibodies are suspected.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance: Limited Standard Use

Short name

IgM Enterocyte Antibody Screen

Frequently asked questions

What Does a Positive Result Indicate?
A positive result suggests the presence of enterocyte-specific antibodies, which could indicate an autoimmune response targeting intestinal cells. This may warrant further investigation, including additional tests or consultations with a specialist, such as a gastroenterologist or immunologist.
Could This Test Detect a Specific Illness?
This test is not a standard diagnostic tool for most gastrointestinal diseases. It may be used in research studies or specialized clinical scenarios, but results should be interpreted alongside other diagnostic findings and clinical symptoms.
How Often Should I Get This Test?
The frequency depends on your healthcare provider’s recommendations. If this test is part of a monitoring plan for a known condition, follow their guidance. If it’s a one-time screening, results may not require repeat testing unless symptoms or clinical circumstances change.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy